BLOG
Life Sciences


IDMP: A Big Data Challenge for European Pharma

Written by Andrew Marr in Life Sciences on 23/05/17


At this year’s AMPLEXOR “Be The Expert 2017” event, Pharm Exec spoke to Andrew Marr about the implications of the EU’s new IDMP (Identification of Medicinal Products) regulations for the pharmaceutical industry.

Read more

Life sciences set for the next stage of a technological revolution

Written by Sonja Vlašič in Life Sciences on 23/05/17


AMPLEXOR recently staged its 19TH annual life sciences conference, BE THE EXPERT 2017. Across three days of debate, discussion and presentations in Budapest, delegates learned more about some of the issues facing the life sciences industry in 2017 and also about some of the technological solutions that are available to address these issues. Elvis Paćelat, Vice President, Life Sciences, AMPLEXOR, gives an overview of what was discussed and where he feels the industry is heading.

Read more

Disrupt or be disrupted: Why the pressure is mounting for life sciences to take digital transformation seriously

Written by Elvis Paćelat in Life Sciences on 31/03/17


All life sciences organizations are under pressure to change. If the preventative healthcare and wellness trend doesn’t turn the industry upside down, it will be something else – from the need for more holistic remedies to the expectation of greater transparency.

Read more

Pursuing World Class RIM Part 4: Authoritative Source and Data Standards Update

Written by Steve Gens in Life Sciences on 03/01/17


Designation of specific RIM systems and repositories as the authoritative source for regulatory information has been the standard for many years as evidenced by our previous RIM research. In 2016 we took the next step towards understanding regulatory information authoritative sources by asking each company to assess their confidence in the data within the authoritative source for 10 essential capabilities.

Read more

Pursuing World Class RIM Part 3: Applying Emerging Technologies in the RIM Space

Written by Steve Gens in Life Sciences on 23/11/16


We have been discussing and anticipating the promise of emerging technology to significantly improve Regulatory Information Management (RIM) systems for the last few years. Historically traditional methods, such as more powerful servers and faster internal networks, shared workspaces and incremental software upgrades have provided relatively little business improvement.

With the advent of significant new regulatory requirements, such as IDMP, and the continuing recognition that regulatory information is a largely underutilized corporate asset, we see four promising emerging technology areas as relevant to world class management of regulatory information.

Read more

Pursuing World Class RIM Part 2: Comparing RIM Operating Models

Written by Steve Gens in Life Sciences on 17/11/16


For years, RIM software vendors have talked about the importance of having a common platform or suite of products for successful management of regulatory information. For industry, a “common” capability requires much more than a set of tools. It requires common processes across sites and geographies, standardized data definitions and entry criteria for the information captured within the RIM systems, as well as enforcement of those standards.

Read more

Pursuing World Class RIM Part 1: What is World Class RIM?

Written by Steve Gens in Life Sciences on 08/11/16


Me and my colleagues (Greg Brolund from Chicopee Falls Consulting and Sarah Powell from Powell Regulatory Services) write an annual white paper to provide a clear industry status of Regulatory Information Management (RIM) highlighting the current state, key trends and priorities, investment focus, projected capability and organization change, and a comprehensive update on the provider landscape. This year we have an exciting addition that focuses on defining and measuring World Class RIM.

This world class journey started in 2014 where a top rated company from our 2014 RIM survey was disappointed in their peer ranking as they rightfully believed there was a tremendous amount of work to be completed and value to be realized. We reflected on this and quickly determined that having just a peer ranking without a target or “gold standard” to achieve would never give a true industry status. We went to work with the help of 18 companies in four design sessions in the fall of 2015 to define the first world class RIM baseline. This entailed detailed discussions and debate of “what is world class RIM?” and more importantly “how do you measure it?”.

Read more

AMPLEXOR´s Digital & Regulatory Transformation @ Momentum Barcelona

Written by Joana Vilhena in Life Sciences on 31/10/16


We’re ready to kick off EMC Momentum in Barcelona Momentum in Barcelona today. AMPLEXOR´s team is excited to meet and spend time with customers, partners and simply curious people, discussing the currently status of the market and the opportunities ahead.

For the last 20 years AMPLEXOR Life Sciences has been helping life sciences organizations accelerate their speed to market and enter new countries quickly. With our solutions and services, we expedite the creation and delivery of consistent, compliant and high-quality global content across all of a company’s target markets.

In this sense, Momentum Summit will be a great chance for us to tell our story, share our experiences and present our vision of the future, with special focus on digital transformation.

Read more

Regulatory transformation: cloud reality check

Written by Siniša Belina in Life Sciences on 19/10/16


An industry debate at AMPLEXOR’s annual user conference in June examined the role of cloud services in driving the next generation of regulatory information management in life sciences, and I want to share with you the main points of the discussion.

The need for regulatory information management (RIM) transformation is driving new interest in cloud services, particularly access to the latest applications via Software as a Service (SaaS) delivery models. But there are different approaches to the cloud, and data sensitivities to consider, so it is rarely a straightforward decision.

It was in this context that AMPLEXOR recently hosted a major industry panel debate, keen to sort the fact from the fiction and establish some best-practice approaches to cloud-based service use in life sciences. The discussion, chaired by Steve Scribner of consultancy The Scribner Group, brought together heavyweight regulatory experts and consultants from across the sector: Romuald Braun of uanotau; Peter Brandstetter of IBM’s GBS Life Sciences team; Torben Thorhauge of NNIT; and Steve Gens of Gens Associates. The audience, made up of AMPLEXOR customers, also participated in the debate.

Read more

3 Reasons You Can’t Miss This Year’s Momentum Europe

Written by Chris McLaughlin in Life Sciences on 06/10/16


It seems hard to believe, but October 31 is just a little more than a month away. Our team is busy putting the finishing touches on Momentum Europe and we are preparing to welcome both business and IT decision-makers from across a number of different industries and from around the globe, including Europe, the Middle East, Africa, Asia and beyond.

Read more